Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Oct 1997, 2618-2622, Vol 35, No. 10
BL Gomez, JI Figueroa, AJ Hamilton, BL Ortiz, MA Robledo, A Restrepo and RJ Hay
Histoplasmosis is an important systemic fungal infection, particularly
among immunocompromised individuals living or travelling in areas of
endemicity, who, without antifungal therapy, may develop a progressive
disseminated fatal infection. For such patients, the detection of antibody
responses by immunodiffusion or complement fixation test is of limited use.
In contrast, the detection of Histoplasma capsulatum circulating antigens
may provide a more practical approach to the rapid diagnosis of the
disease. Accordingly, an inhibition enzyme-linked immunosorbent assay
(ELISA) for the detection of a 69- to 70-kDa H. capsulatum-specific
determinant and incorporating a species-specific murine monoclonal antibody
was developed. With sera from patients with different forms of the disease
(n = 35), the overall sensitivity of the test was found to be 71.4%, while
the specificity was found to be 98% with normal human sera from areas of
endemicity (n = 44) and 85.4% with sera from patients with other chronic
fungal or bacterial infections (n = 48). This novel, highly specific ELISA
provides a significant addition to the existing diagnostic tests for the
detection of histoplasmosis.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Development of a novel antigen detection test for histoplasmosis
Corporacion para Investigaciones Biologicas, Medellin, Colombia.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|